High-dose oral vitamin D reduced skin inflammation and increased immunoprotection in patients with chemical-induced skin rashes, according to findings from a recent clinical trial.
The World Health Organization (WHO) has quietly shelved the second phase of its much-anticipated scientific investigation into the origins of the COVID-19 pandemic, citing ongoing challenges over attempts to conduct crucial studies in China.
A review of clinical trials has found that higher vitamin D intake was associated with a 15 percent decreased likelihood for developing type 2 diabetes in adults with prediabetes.
More than 30 research papers published between 2000 and 2022 have confirmed that a chemical component found in green tea can help fight various types of coronaviruses, including variants of COVID-19.
A new study hints that treating low vitamin D levels with supplements might have a critical benefit for certain people: a decreased risk of attempting suicide.
Several new government- and industry-funded studies are underway to develop mRNA vaccines for livestock, part of the massive expansion of the animal vaccine industry projected to be worth $26.12 billion by 2030.
Tackling Skin Inflammation With Vitamin D